Cargando…

A T-cell-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma based on transcriptomics and single-cell sequencing

BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most frequently diagnosed malignancy and the third leading cause of cancer death globally. T cells are significantly correlated with the progression, therapy and prognosis of cancer. Limited systematic studies regarding the role of T-cell-relat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xu, Peng, Chuang, Chen, Yu, Ding, Bai, Liu, Sulai, Song, Yinghui, Li, Yuhang, Sun, Bo, Yang, Ranzhiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210368/ https://www.ncbi.nlm.nih.gov/pubmed/37231356 http://dx.doi.org/10.1186/s12859-023-05344-7

Ejemplares similares

Insights into the role of STAT3 in intrahepatic cholangiocarcinoma
por: Yang, Ranzhiqiang, et al.
Publicado: (2022)

Vascular endothelial growth factor A is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma
por: Qi, Yuchen, et al.
Publicado: (2023)

A novel stemness-hypoxia-related signature for prognostic stratification and immunotherapy response in hepatocellular carcinoma
por: Zhang, Genhao, et al.
Publicado: (2022)

PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma
por: Yu, Zhangtao, et al.
Publicado: (2021)

S100A family is a group of immune markers associated with poor prognosis and immune cell infiltration in hepatocellular carcinoma
por: Qi, Yuchen, et al.
Publicado: (2023)

Prognostic stratification based on m(5)C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma
por: Liu, Ping, et al.
Publicado: (2022)

Mechanisms underlying the changes in acetaldehyde dehydrogenase 1 in cholangiocarcinoma
por: Ding, Bai, et al.
Publicado: (2023)

The new insight of treatment in Cholangiocarcinoma
por: Li, Yuhang, et al.
Publicado: (2022)

Correction to: The focus clinical research in intrahepatic cholangiocarcinoma
por: Song, Yinghui, et al.
Publicado: (2022)

Progress in gallbladder cancer with lymph node metastasis
por: Li, Yuhang, et al.
Publicado: (2022)

The focus clinical research in intrahepatic cholangiocarcinoma
por: Song, Yinghui, et al.
Publicado: (2022)

A novel tumor immunotherapy-related signature for risk stratification, prognosis prediction, and immune status in hepatocellular carcinoma
por: Sun, Jianping, et al.
Publicado: (2023)

Prognostic pyroptosis-related lncRNA signature predicts the efficacy of immunotherapy in hepatocellular carcinoma
por: Cheng, Zina, et al.
Publicado: (2022)

Identification of a Prognostic Transcriptome Signature for Hepatocellular Carcinoma with Lymph Node Metastasis
por: Ma, Jie, et al.
Publicado: (2022)

Title: Multi-Omics and Immune Landscape of Proliferative LncRNA Signatures: Implications for Risk Stratification and Immunotherapy in Hepatocellular Carcinoma
por: Liu, Chi, et al.
Publicado: (2022)

An immune subtype-related prognostic signature of hepatocellular carcinoma based on single-cell sequencing analysis
por: Xie, Jiaheng, et al.
Publicado: (2022)

Immune classifier-based signatures provide good prognostic stratification and predict the clinical benefits of immune-based therapies for hepatocellular carcinoma
por: Xue, Chen, et al.
Publicado: (2021)

Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma
por: Liang, Fangfang, et al.
Publicado: (2021)

Transcriptomic signature associated with RNA-binding proteins for survival stratification of laryngeal cancer
por: Shen, Yujie, et al.
Publicado: (2022)

IMMU-27. ANALYSIS OF IMMUNE SIGNATURES IN PEDIATRIC GLIOBLASTOMAS FOR PATIENT STRATIFICATION TO IMMUNOTHERAPY
por: Chandramohan, Vidyalakshmi, et al.
Publicado: (2020)

Identification of PANoptosis-Based Prognostic Signature for Predicting Efficacy of Immunotherapy and Chemotherapy in Hepatocellular Carcinoma
por: Xiong, Xiaofeng, et al.
Publicado: (2023)

Follicular Helper T-Cell-Based Classification of Endometrial Cancer Promotes Precise Checkpoint Immunotherapy and Provides Prognostic Stratification
por: Chen, Yi, et al.
Publicado: (2022)

Role of Immune Cell-Specific Hypermethylation Signatures in Classification and Risk Stratification of Breast Cancer
por: Chen, Yong, et al.
Publicado: (2021)

Transcriptomic characterization reveals prognostic molecular signatures of sorafenib resistance in hepatocellular carcinoma
por: Yuan, Wei, et al.
Publicado: (2021)

A Novel Prognostic Signature of comprising Nine NK Cell signatures Based on Both Bulk RNA Sequencing and Single-Cell RNA Sequencing for Hepatocellular Carcinoma
por: Yu, Qi, et al.
Publicado: (2023)

Prognostic value of DNA repair based stratification of hepatocellular carcinoma
por: Lin, Zhuo, et al.
Publicado: (2016)

Efferocytosis signatures as prognostic markers for revealing immune landscape and predicting immunotherapy response in hepatocellular carcinoma
por: Xu, Ke, et al.
Publicado: (2023)

Identification of an inflammatory response signature associated with prognostic stratification and drug sensitivity in lung adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2022)

Identification of a Ferroptosis-Related Long Noncoding RNA Prognostic Signature and Its Predictive Ability to Immunotherapy in Hepatocellular Carcinoma
por: Wang, Liang, et al.
Publicado: (2021)

A novel ROS-Related chemiluminescent semiconducting polymer nanoplatform for acute pancreatitis early diagnosis and severity assessment
por: Li, Yuhang, et al.
Publicado: (2023)

Mast Cells Resting-Related Prognostic Signature in Hepatocellular Carcinoma
por: Zhang, Hao, et al.
Publicado: (2021)

Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma
por: Li, Quanxiao, et al.
Publicado: (2021)

Cancer-associated fibroblast-related prognostic signature predicts prognosis and immunotherapy response in pancreatic adenocarcinoma based on single-cell and bulk RNA-sequencing
por: Chen, Yajun, et al.
Publicado: (2023)

A Prognostic Gene Signature for Hepatocellular Carcinoma
por: Chen, Rong, et al.
Publicado: (2022)

RCC Real-World Data: Prognostic Factors and Risk Stratification in the Immunotherapy Era
por: Sagie, Shira, et al.
Publicado: (2022)

Immunogenic cell death-related classifications in breast cancer identify precise immunotherapy biomarkers and enable prognostic stratification
por: Wang, Xue, et al.
Publicado: (2022)

A Nucleotide Metabolism-Related Gene Signature for Risk Stratification and Prognosis Prediction in Hepatocellular Carcinoma Based on an Integrated Transcriptomics and Metabolomics Approach
por: Wei, Tianfu, et al.
Publicado: (2023)

A Novel Pyroptosis-Related Prognostic Signature for Risk Stratification and Clinical Prognosis in Clear Cell Renal Cell Carcinoma
por: Pan, Xiao-qiong, et al.
Publicado: (2022)

The pros and cons of the PCC staging system to guide surgical resectability and prognosis
por: Liu, Pei, et al.
Publicado: (2022)

Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients
por: Hu, Bo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7rq6a37d2pu55ei82qmdec0b8g